APA

Gu B., Xiong H., Zhou Y., Chen B., Wang L., Dong S., Yu Z., Lu L., Zhong M., Yin H., Zhu G., Huang W., Ren S., Gallagher R. E., Waxman S., Chen G., Wang Z., Chen Z., Fu G. & Chen S. (20020701). Variant-type PML-RAR(alpha) fusion transcript in acute promyelocytic leukemia: use of a cryptic coding sequence from intron 2 of the RAR(alpha) gene and identification of a new clinical subtype resistant to retinoic acid therapy. : Proceedings of the National Academy of Sciences of the United States of America.

Chicago

Gu Bai-Wei, Xiong Hui, Zhou Yan, Chen Bing, Wang Li, Dong Shuo, Yu Zhi-Yuan, Lu Ling-Feng, Zhong Ming, Yin Hai-Feng, Zhu Gen-Feng, Huang Wei, Ren Shuang-Xi, Gallagher Robert E, Waxman Samuel, Chen Guo-Qiang, Wang Zhu-Gang, Chen Zhu, Fu Gang and Chen Sai-Juan. 20020701. Variant-type PML-RAR(alpha) fusion transcript in acute promyelocytic leukemia: use of a cryptic coding sequence from intron 2 of the RAR(alpha) gene and identification of a new clinical subtype resistant to retinoic acid therapy. : Proceedings of the National Academy of Sciences of the United States of America.

Harvard

Gu B., Xiong H., Zhou Y., Chen B., Wang L., Dong S., Yu Z., Lu L., Zhong M., Yin H., Zhu G., Huang W., Ren S., Gallagher R. E., Waxman S., Chen G., Wang Z., Chen Z., Fu G. and Chen S. (20020701). Variant-type PML-RAR(alpha) fusion transcript in acute promyelocytic leukemia: use of a cryptic coding sequence from intron 2 of the RAR(alpha) gene and identification of a new clinical subtype resistant to retinoic acid therapy. : Proceedings of the National Academy of Sciences of the United States of America.

MLA

Gu Bai-Wei, Xiong Hui, Zhou Yan, Chen Bing, Wang Li, Dong Shuo, Yu Zhi-Yuan, Lu Ling-Feng, Zhong Ming, Yin Hai-Feng, Zhu Gen-Feng, Huang Wei, Ren Shuang-Xi, Gallagher Robert E, Waxman Samuel, Chen Guo-Qiang, Wang Zhu-Gang, Chen Zhu, Fu Gang and Chen Sai-Juan. Variant-type PML-RAR(alpha) fusion transcript in acute promyelocytic leukemia: use of a cryptic coding sequence from intron 2 of the RAR(alpha) gene and identification of a new clinical subtype resistant to retinoic acid therapy. : Proceedings of the National Academy of Sciences of the United States of America. 20020701.